XML 128 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Schedule of Cash and Marketable Securities by Significant Investment Category (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Cash and Cash Equivalents [Line Items]    
Adjusted Cost $ 62,922,000 $ 73,929,000
Adjusted Cost 67,285,000 73,929,000
Unrealized Gain/(Loss) 3,042,000 1,544,000
Fair Value 70,327,000 75,473,000
Cash and Cash Equivalents 43,945,000 56,595,000
Restricted cash
Marketable Securities 17,224,000 14,537,000
Notes receivable  
Investments 9,158,000 4,341,000
Fair Value, Inputs, Level 2 [Member] | Convertible Securities [Member]    
Cash and Cash Equivalents [Line Items]    
Adjusted Cost 1,023,000
Adjusted Cost 1,023,000 1,023,000
Unrealized Gain/(Loss) 1,135,000
Fair Value 2,158,000 1,023,000
Cash and Cash Equivalents
Restricted cash
Marketable Securities
Notes receivable  
Investments 2,158,000 1,023,000
Fair Value, Inputs, Level 2 [Member] | Warrant [Member]    
Cash and Cash Equivalents [Line Items]    
Adjusted Cost   3,318,000
Adjusted Cost 3,318,000 3,318,000
Unrealized Gain/(Loss) 3,682,000
Fair Value 7,000,000 3,318,000
Cash and Cash Equivalents
Restricted cash
Marketable Securities
Notes receivable  
Investments 7,000,000 3,318,000
Cash [Member]    
Cash and Cash Equivalents [Line Items]    
Adjusted Cost 40,811,000 50,286,000
Adjusted Cost 40,811,000 50,286,000
Unrealized Gain/(Loss)
Fair Value 40,811,000 50,286,000
Cash and Cash Equivalents 40,811,000 50,286,000
Restricted cash
Marketable Securities
Notes receivable  
Investments
Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]    
Cash and Cash Equivalents [Line Items]    
Adjusted Cost 3,134,000 6,309,000
Adjusted Cost 3,134,000 6,309,000
Unrealized Gain/(Loss)
Fair Value 3,134,000 6,309,000
Cash and Cash Equivalents 3,134,000 6,309,000
Restricted cash
Marketable Securities
Notes receivable  
Investments
Marketable Securities [Member] | Fair Value, Inputs, Level 1 [Member]    
Cash and Cash Equivalents [Line Items]    
Adjusted Cost 18,977,000 12,993,000
Adjusted Cost 18,999,000 12,993,000
Unrealized Gain/(Loss) (1,775,000) 1,544,000
Fair Value 17,224,000 14,537,000
Cash and Cash Equivalents
Restricted cash
Marketable Securities 17,224,000 14,537,000
Notes receivable  
Investments